Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (ABC-X)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03340129 |
|
Recruitment Status :
Recruiting
First Posted : November 13, 2017
Last Update Posted : October 27, 2022
|
Sponsor:
Melanoma Institute Australia
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Melanoma Institute Australia
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2023 |
| Estimated Study Completion Date : | August 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):